newsfilter
← Latest News
PR Newswire·

Compugen Reports Third Quarter 2025 Results

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...